International Clinical Trial: Randomized Controlled Study on Efficacy and Safety of Subcutaneous Methotrexate Injection in the Treatment of Active Takayasu Arteritis

Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132558) titled 'Randomized Controlled Study on Efficacy and Safety of Subcutaneous Methotrexate Injection in the Treatment of Active Takayasu Arteritis' on Sept. 15.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Beijing Anzhen Hospital, Capital Medical University

Condition: Takayasu arteritis (TAK) is a rare, chronic autoimmune large-vessel vasculitis that primarily affects the aorta and its major branches, characterized by granulomatous inflammation of the vessel wall. It predominantly affects young and middle-aged women and is associated with high mortality. Clinical manifestations include syst...